Revenue Growth: 4% overall revenue growth. Net Profit Growth: 1% net profit growth. Cochlear Implant Revenue: 9% growth in cochlear implant revenue, with 12% growth in systems. Developed Markets Unit ...

Cochlear has collapsed 65% in 2026 after a brutal guidance cut. But the long-term investment case for the business may still ...

MEBOURNE, Australia – Cochlear Ltd., the world's biggest maker of bionic ears, Monday recalled its latest range of hearing implants after a recent unexplained increase in failures. Cochlear shares ...

The valuation now looks far more interesting for a healthcare stock with a global leadership position. The post Could this fallen ASX 200 stock be a once-in-a-decade opportunity? appeared first on The ...

If you want to know who really controls Cochlear Limited (ASX:COH), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the company with ...

Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Cochlear ( ...

The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...